Dr. Chiara Gai earned a PhD in Medical Pathophysiology from the Department of Medical Sciences of the University of Turin in 2017. Dr. Gai is working with Prof. Camussi since 2014 in the field of EV derived from stem cells. She set up several in vitro tests for the assessment of the minimal efficacious dose of EV, to measure EV biologic activity and their pro-angiogenic properties, their ability to promote cell proliferation, apoptosis, cell migration, oxidative stress and ROS production. She has also experience in molecular characterization of EV from different sources. Dr. Gai is co-founder and chair of EvoBiotech since February 2019.